Finally! A sign of life (at least publicly) from Therabiologics (GenVec's partner) about success with their glioma program! Hopefully the next release will give details of commencement of the clinical trial for TBX-02, which was scheduled to begin late this year. Here's the link: http://clincancerres.aacrjournals.org/content/early/2016/12/15/1078-0432.CCR-16-1518
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.